Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2022. Go to the latest filing (Q3 2026)

19.9B USDQ4 2022
Total value of stock positions
19.9B USD
Positions
75
Share of the ten largest
41.8%

The ten largest positions Q4 2022

  1. Visa Inc. 6.0%▲ +8.2%
  2. Amazon 5.3%▲ +34.4%
  3. Elevance Health 4.8%▼ −19.9%
  4. McKesson Corporation 4.2%▼ −15.5%
  5. Microsoft 4.1%▼ −2.3%
  6. Chubb Limited 4.0%▼ −0.4%
  7. Roivant Sciences Ltd 3.5%unchanged
  8. UnitedHealth Group 3.4%▲ +263.7%
  9. GE Aerospace 3.3%▼ −39.6%
  10. Api Group Corp 3.2%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2022

Positions Q4 2022 per 13F filing, 27 of 27
Symbol Weight Shares Reported value Change Held since
ELV Elevance Health 4.8% 1,872,176 960.4M USD −19.9% reduced Q1 2022 4 quarters
MCK McKesson Corporation 4.2% 2,204,418 826.9M USD −15.5% reduced Q2 2022 3 quarters
MSFT Microsoft 4.1% 3,429,127 822.4M USD −2.3% reduced Q2 2016 27 quarters
CB Chubb Limited 4.0% 3,580,128 789.8M USD −0.4% reduced Q1 2020 12 quarters
GE GE Aerospace 3.3% 7,775,177 651.5M USD −39.6% reduced Q4 2020 9 quarters
MA Mastercard 3.0% 1,709,228 594.3M USD −3.5% reduced Q1 2022 4 quarters
Hdfc Bank Ltd 2.9% 8,570,740 586.3M USD −11.8% reduced Q3 2021 6 quarters
AMP Ameriprise Financial 2.6% 1,647,855 513.1M USD −8.7% reduced Q1 2021 8 quarters
BSX Boston Scientific 2.2% 9,528,593 440.9M USD −41.0% reduced Q3 2018 18 quarters
Royalty Pharma PLC 2.0% 10,008,511 395.5M USD −8.0% reduced Q2 2020 11 quarters
META Meta Platforms 1.4% 2,387,730 287.3M USD −55.4% reduced Q4 2020 9 quarters
XYZ Block, Inc. 1.4% 4,483,754 281.8M USD −15.6% reduced Q4 2021 5 quarters
FTV Fortive 1.3% 3,890,600 250.0M USD −36.0% reduced Q3 2019 14 quarters
UBER Uber 1.0% 7,939,999 196.4M USD −51.6% reduced Q3 2021 6 quarters
Amylyx Pharmaceuticals Inc 0.9% 4,634,606 171.2M USD −19.7% reduced Q1 2022 4 quarters
Valvoline Inc 0.8% 4,876,780 159.2M USD −16.6% reduced Q3 2022 2 quarters
Unum Group 0.7% 3,431,274 140.8M USD −32.4% reduced Q1 2022 4 quarters
Inspire Med Sys Inc 0.7% 549,793 138.5M USD −13.2% reduced Q1 2022 4 quarters
CRL Charles River Laboratories 0.6% 515,168 112.3M USD −21.8% reduced Q1 2021 8 quarters
Ginkgo Bioworks Holdings Inc 0.5% 63,085,126 106.6M USD −38.1% reduced Q3 2021 6 quarters
PODD Insulet Corporation 0.4% 268,052 78.9M USD −56.1% reduced Q3 2020 10 quarters
DG Dollar General 0.4% 310,848 76.5M USD −87.2% reduced Q1 2022 4 quarters
Catalent Inc 0.3% 1,424,388 64.1M USD −14.9% reduced Q1 2018 20 quarters
Zai Lab Ltd 0.3% 1,973,597 60.6M USD −24.5% reduced Q1 2021 8 quarters
IFF International Flavors & Fragrances 0.2% 439,360 46.1M USD −88.2% reduced Q4 2021 5 quarters
PGR Progressive Corporation 0.2% 336,861 43.7M USD −54.3% reduced Q1 2022 4 quarters
Pepgen Inc 0.1% 1,544,631 20.7M USD −13.9% reduced Q2 2022 3 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 75.2M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 75.2M USD

Breakdown by sector

  • Financials 18.0%
  • Health Care 17.9%
  • Technology 12.2%
  • Industrials 7.9%
  • Consumer Discretionary 5.3%
  • Communication Services 1.4%
  • Consumer Staples 0.9%
  • Materials 0.6%
  • not in our coverage 35.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close